Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

McMillan, AK; Phillips, EH; Kirkwood, AA; Barrans, S; Burton, C; Rule, S; Patmore, R; Pettengell, R; Ardeshna, KM; Lawrie, A; Montoto, S; Paneesha, S; Clifton-Hadley, L; Linch, DC

McMillan, AK (corresponding author), Nottingham City Hosp, Haematol Dept, Hucknall Rd, Nottingham NG5 1PB, England.

ANNALS OF ONCOLOGY, 2020; 31 (9): 1251

Abstract

Background: Outcomes for patients with high-risk diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy are suboptimal but, to date, n......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索